-+ 0.00%
-+ 0.00%
-+ 0.00%

TriSalus Life Sciences Lowers FY2026 Sales Guidance from $60.000M-$62.000M to $54.000M-$57.000M vs $59.960M Est

Benzinga·05/12/2026 20:03:17
Listen to the news
TriSalus Life Sciences (NASDAQ:TLSI) lowers FY2026 sales outlook from $60.000 million-$62.000 million to $54.000 million-$57.000 million vs $59.960 million estimate.